Novabase S.G.P.S., S.A. (LON:0MTZ)

Oncternal Therapeutics Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 7, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	256	165	111	108	131	87
Market Cap Growth	54.81%	49.33%	2.75%	-17.73%	50.38%	32.12%
Enterprise Value	257	139	122	78	103	60
Last Close Price	6.78	4.23	3.14	2.63	2.62	1.87
PE Ratio	34.81	31.17	2.71	13.64	17.93	13.00
PS Ratio	2.30	1.49	0.96	1.01	1.13	0.78
PB Ratio	5.39	2.36	1.47	1.81	2.06	1.45
P/TBV Ratio	9.04	3.16	1.93	2.74	2.91	2.16
P/FCF Ratio	-	-	7.09	102.09	20.27	18.42
P/OCF Ratio	-	-	6.92	62.81	18.38	16.37
EV/Sales Ratio	2.30	1.25	1.06	0.73	0.88	0.53
EV/EBITDA Ratio	28.86	16.86	17.16	12.80	12.26	5.90
EV/EBIT Ratio	26.57	18.05	18.82	14.68	13.40	9.43
EV/FCF Ratio	-	-	7.79	73.51	15.92	12.62
Debt / Equity Ratio	0.31	0.24	0.32	0.20	0.29	0.46
Debt / EBITDA Ratio	1.68	1.56	2.55	1.42	1.76	2.13
Debt / FCF Ratio	-	-	1.54	11.13	2.86	5.86
Asset Turnover	0.87	0.79	0.81	0.76	0.83	0.69
Inventory Turnover	-	-	-	-	10107.77	3645.23
Quick Ratio	1.57	2.11	1.91	1.39	1.61	1.65
Current Ratio	1.58	2.20	2.03	1.49	1.70	1.74
Return on Equity (ROE)	13.04%	7.68%	4.44%	5.23%	12.47%	4.93%
Return on Assets (ROA)	4.69%	3.42%	2.86%	2.37%	3.41%	2.44%
Return on Capital (ROIC)	7.81%	5.27%	4.77%	4.18%	5.83%	4.09%
Return on Capital Employed (ROCE)	15.30%	8.60%	6.70%	7.80%	9.70%	7.20%
Earnings Yield	2.87%	3.21%	36.85%	7.33%	5.58%	7.69%
FCF Yield	-	-0.75%	14.11%	0.98%	4.93%	5.43%
Dividend Yield	14.30%	26.37%	49.41%	3.99%	-	-
Payout Ratio	-	721.28%	23.01%	-	-	-
Buyback Yield / Dilution	-31.07%	-17.36%	-4.55%	-0.26%	-0.79%	0.75%
Total Shareholder Return	-16.77%	9.02%	44.86%	3.72%	-0.79%	0.75%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.